Adam Cuker
Director, Penn Comprehensive and Hemophilia Thrombosis Program · University of Pennsylvania Health System
Credentials: · · · ·
History
PresentPenn Comprehensive and Hemophilia Thrombosis Program · University of Pennsylvania Health System
- 2015–2016
- 2003–2006
1999–2003
Research
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
PLoS Medicine · 2006 · 1,170 citations
Blood Advances · 2020 · 1,107 citations
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Blood Advances · 2019 · 1,051 citations
27 papers
22 papers · 5 as a fellow
- HS
15 papers
12 papers
- AL
11 papers
11 papers
10 papers
- BK
9 papers
Grants
- 2019–2024
National Heart, Lung, and Blood Institute · R44
PI · $1.6M · Flobio, Llc
- 2012–2015
Improving the Diagnosis of Heparin-Induced Thrombocytopenia
National Heart, Lung, and Blood Institute · K23
Contact PI · $435.6K · University of Pennsylvania
Clinical trials
- 2021–2022
OsciPulse Device for the Prevention of VTE
Principal investigator · Completed
University of Pennsylvania
- 2025–2029
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
- 2025–2028
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
- 2020–2035
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Site PI · Recruiting
American Thrombosis and Hemostasis Network